Literature DB >> 339851

Immune reactants in cryoproteins. Relationship to complement activation.

M R Wilson, C M Arroyave, L Miles, E M Tan.   

Abstract

Cryoproteins were isolated from the serum of 5 patients with essential cryoglobulinaemia 5 patients with rheumatoid arthritis, and 2 patients with Sjøgren's syndrome. These cryoprecipitates contained IgG, IgM, and IgA as well as complement proteins C1q, C4, C3, and factor B. The cryoprecipitates were analysed further for content of antibody and antigen, and were tested for their ability to activate complement. In the cryoprecipitates of 2 patients with Sjøgren's syndrome, nuclear antigen and antinuclear antibody characteristic of an immunological specificity found in Sjøgren's syndrome were shown. The cryoprecipitates of 6 other patients contained rheumatoid factor and antibody to a lymphocyte nuclear antigen. The solubilized cryoprecipitates were tested by in vitro assays for their ability to activate complement by the classical or alternative pathways. All 12 cryoprecipitates activated the classical pathway. 9 of the 12 cryoprecipitates also activated the alternative complement pathway under conditions which did not involve activation of C1 and C4. These studies show that a high percentage of cryoprecipitates consist at least in part of immune reactants. We discuss the relationship of these findings to pathogenetic mechanisms in disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 339851      PMCID: PMC1000160          DOI: 10.1136/ard.36.6.540

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Biologically active water-insoluble protein polymers. I. Their use for isolation of antigens and antibodies.

Authors:  S Avrameas; T Ternynck
Journal:  J Biol Chem       Date:  1967-04-10       Impact factor: 5.157

4.  Cold-insoluble complexes and complement levels in systemic lupus erythematosus.

Authors:  P Stastny; M Ziff
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

5.  Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

Authors:  M Meltzer; E C Franklin; K Elias; R T McCluskey; N Cooper
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

6.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

7.  Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes.

Authors:  P F Kohler; R E Cronin; W S Hammond; D Olin; R I Carr
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

8.  The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.

Authors:  J R Wands; E Mann; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

9.  Detection of complement activation by counterimmunoelectrophoresis (CIE).

Authors:  C M Arroyave; E M Tan
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

10.  Studies of cryoproteins in systemic lupus erythematosus.

Authors:  L B Hanauer; C L Christian
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

View more
  8 in total

1.  Plasma fibronectin is a component of cryoglobulins from patients with connective tissue and other diseases.

Authors:  B Anderson; M Rucker; R Entwistle; F R Schmid; G W Wood
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

2.  Occurrence of C-reactive protein in cryoglobulins.

Authors:  S M Weiner; V Prasauskas; D Lebrecht; S Weber; H H Peter; P Vaith
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  Cryoglobulins in cases of rheumatoid arthritis.

Authors:  D Chattopadhya; B Ravindran; K Prakash
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

4.  Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.

Authors:  C C Erhardt; P Mumford; R N Maini
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

5.  Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.

Authors:  I Kono; T Sakurai; T Kabashima; K Yamane; H Kashiwagi
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

6.  Interaction of plasma fibronectin with selected cryoglobulins.

Authors:  G Wood; M Rucker; J W Davis; R Entwistle; B Anderson
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

7.  Cryoimmunoglobulinaemia in patients with renal disease. II attempts to demonstrate-that cryoprecipitate contain autoantibodies and/or antigen.

Authors:  J J McPhaul; R Montgomery
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

8.  Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren's Syndrome.

Authors:  Jingxiu Xuan; Zhiqian Ji; Bin Wang; Xiaoli Zeng; Rongjuan Chen; Yan He; Peishi Rao; Puqi Wu; Guixiu Shi
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.